Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings ...

Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- ...

Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV. Late presentation of advanced HIV is most common in patients of older age and ...

• First presentation of a novel approach to potentially cure HIV - An in vivo study demonstrated a 164 percent increase in engraftment of genetically modified cells More than 39 million people live ...

GSK hosted an analyst presentation on its HIV segment (close to 20% of total sales) signaling increased focus on developing longer-duration therapies. While the updates don’t have an impact on our ...

We showed a progressive improvement in earlier diagnosis with time in those diagnosed under the age of 50 years but strikingly the likelihood of late presentation in those over 50 years of age ...

Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India There are only limited ...

A recent study found a method to increase enrollment among high-risk individuals in HIV prevention programs. A recent study by University of Illinois professor of psychology Dolores Albarracín and her ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the results from studies evaluating MK-8591, an investigational nucleoside ...

Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. This exogenous pathway may have a crucial role in the activation of CD8 + cytotoxic T ...